KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Depreciation & Amortization (CF) (2016 - 2025)

Elevance Health (ELV) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $406.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 2.01% to $406.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 10.98% increase, with the full-year FY2025 number at $1.5 billion, up 10.98% from a year prior.
  • Depreciation & Amortization (CF) was $406.0 million for Q4 2025 at Elevance Health, up from $387.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $473.0 million in Q4 2022 to a low of $282.0 million in Q1 2021.
  • A 5-year average of $383.0 million and a median of $383.5 million in 2025 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): surged 31.39% in 2022, then dropped 28.35% in 2024.
  • Elevance Health's Depreciation & Amortization (CF) stood at $360.0 million in 2021, then soared by 31.39% to $473.0 million in 2022, then dropped by 10.36% to $424.0 million in 2023, then fell by 6.13% to $398.0 million in 2024, then increased by 2.01% to $406.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Depreciation & Amortization (CF) are $406.0 million (Q4 2025), $387.0 million (Q3 2025), and $380.0 million (Q2 2025).